Prostate Cancer
Showing 9976 - 10000 of >10,000
Stored Tumor Samples in Young Patients With Brain Tumors
Recruiting
- Brain and Central Nervous System Tumors
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 5, 2022
Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))
Completed
- Cancer of Kidney
- +6 more
- 124-Iodine-cG250 (124I-cG250)
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Oct 3, 2022
Breast Cancer Trial in Boston, Pittsburgh, Dallas (Nivolumab, Ipilimumab)
Active, not recruiting
- Breast Cancer
-
Boston, Massachusetts
- +2 more
Oct 21, 2022
Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)
Recruiting
- Viral Associated Malignancies
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Head Neck Cancer, Trismus, Dysfunction Trial in Temuco (Manual Therapy, Control motor exercises)
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Manual Therapy
- Control motor exercises
-
Temuco, Cautin, ChileUniversidad de La Frontera
Nov 17, 2023
Pancreatic Cancer Recurrence in the Netherlands
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
-
Utrecht, NetherlandsUMC Utrecht
Feb 1, 2023
Ovarian Cancer Trial in Wuhan (fluzoparib monotherapy or combination therapy)
Recruiting
- Ovarian Cancer
- fluzoparib monotherapy or combination therapy
-
Wuhan, Hubei, ChinaTongji Hospital of Tongji Medical College, Huazhong University o
Jan 25, 2022
Metastatic Nasopharyngeal Carcinoma, Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Metastatic Nasopharyngeal
Active, not recruiting
- Metastatic Nasopharyngeal Carcinoma
- +10 more
- Carboplatin
- +4 more
-
Birmingham, Alabama
- +324 more
Jun 28, 2022
Secondary Lymphedema Trial in Helsinki, Tampere, Turku (Lymfactin® [1 x 10E10 vp], Lymfactin® [1 x 10E11 vp])
Active, not recruiting
- Secondary Lymphedema
- Lymfactin® [1 x 10E10 vp]
- Lymfactin® [1 x 10E11 vp]
-
Helsinki, Finland
- +2 more
Mar 16, 2022
Anlotinib Retrospective Study for Esophageal Cancer
Completed
- Esophageal Neoplasms
-
Zhengzhou, Henan, ChinaThe First Affiliated Hospital of Zhengzhou University
Mar 27, 2022
Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality
Recruiting
- Breast Cancer Stage IV
- comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
-
Mansoura, Dakahlia, EgyptOncology center mansoura university
Jan 1, 2023
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Head Neck Cancer Trial in Boston (Oral Decitabine, Durvalumab)
Active, not recruiting
- Head and Neck Cancer
- Oral Decitabine
- Durvalumab
-
Boston, MassachusettsMassachusetts General Hospital
Oct 30, 2022
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer
Completed
- Skin Cancer
- skin specimen
-
Irvine, California
- +1 more
Oct 28, 2022
Cancer of Rectum Trial in Denmark (50.4 Gy to the tumor and elective volume, 62 Gy to the clinical tumor volume and 50.4 Gy to
Recruiting
- Cancer of Rectum
- 50.4 Gy to the tumor and elective volume
- +2 more
-
Aalborg, Denmark
- +4 more
May 24, 2022
Screening Contrast-enhanced Mammography
Recruiting
- Breast Cancer
-
Quebec City, Quebec, CanadaSt-Sacrement Hospital
May 20, 2022
Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)
Completed
- Malignant Neoplasms of Digestive Organs
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 23, 2022
Advanced Non-small-cell Lung Cancer Trial in Shanghai (AK112, AK104, caboplatin)
Not yet recruiting
- Advanced Non-small-cell Lung Cancer
- AK112
- +5 more
-
Shanghai, ChinaShanghai Pulmonary Hospital
Jun 6, 2023
HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)
Active, not recruiting
- HER2-positive Breast Cancer
- TQB2440 injection + Trastuzumab + Docetaxel
- Perjeta + Trastuzumab + Docetaxel
-
Chongqing, Chongqing, China
- +5 more
Aug 3, 2023
Melanoma (Skin) Trial in Stockholm (LifeChamps Platform)
Active, not recruiting
- Melanoma (Skin)
- LifeChamps Platform
-
Stockholm, SwedenAcademic Primary Health Care Centre
Aug 6, 2023
Self-Collected Swabs for Primary Human Papilloma Virus Screening
Not yet recruiting
- HPV
- Self-swab for genital HPV
- (no location specified)
Aug 9, 2023
Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)
Active, not recruiting
- Mantle Cell Lymphoma
- R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
-
Basking Ridge, New Jersey
- +4 more
Dec 1, 2022
Radiomics for prEdiction of lunG cAncer biologY
Active, not recruiting
- Non Small Cell Lung Cancer
- +3 more
- PET/CT
-
Poitiers, FranceCHU Poitiers
Apr 5, 2023
Tumor Tissue Samples From Newly Diagnosed Neuroblastoma or
Recruiting
- Ganglioneuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +258 more
Mar 23, 2022